Gurská Soňa Ph.D.

Journals

TANGALLAPALLI, S., R. GUNDLA, K. PAIDIKONDALA, S. GURSKÁ, N. RAMPEESA, S. ANUGU, P. DŽUBÁK, M. HAJDÚCH, V. DAS, N. KATARI
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances. 2025, 15(55), 47565-47586, ISSN: 2046-2069, PMID: 41356712,  PDF.
ORSÁG, Š., I. FRYDRYCH, B. LIŠKOVÁ, S. GURSKÁ, A. PRIBYLKA, J. HODOŇ, P. DŽUBÁK, M. HAJDÚCH, M. URBAN
Synthesis and biological evaluation of novel C-30 modified lupane triterpenoids selectively cytotoxic against cancer cells. European Journal of Medicinal Chemistry. 2025, 302 (Pt 1), 118268, ISSN: 0223-5234 , PMID: 41124881,  PDF.
SROVNALOVÁ, A., R. KAPLANEK, Z. KEJIK, J. HAJDUCH, S. GURSKÁ, P. MARTASEK, M. HAJDÚCH, P. DŽUBÁK, M. JAKUBEK
Synthesis and evaluation of cyclobut-3-ene-1,2-dione-3-hydrazones with benzothiazole moiety as novel anticancer agents inducing nonapoptotic oncosis-like cell death. Biomedicine & pharmacotherapy. 2025, ISSN: 0753-3322, PMID: 40763487,

Books & book chapters

GURSKÁ, S.
Analysis of cytotoxicity by tetrazolium salt reduction test , 1.vyd., Olomouc, Palacky University, 2021, 10, 67-72, Dedication: LO1304, ISBN: 978-80-244-6049-9,

Intellectual property

RNA ISOLATION KIT (Džubák)

Utility Model: CZ 35067. Granted: 18.5.2021. Ownership: Palacký University Olomouc. Inventors: DŽUBÁK Petr, HAJDÚCH Marián, GURSKÁ Soňa, KOUDELÁKOVÁ Vladimíra, JAWOREK Hana.

Status: Available

Master mentorship

Synek Vojtěch

Development of the assay for measurement of the CA activity and its implementation into HTS

Stav: Absolvoval od 2018 do 2020.
Dostálová Kristýna

Cell-based assays for high-throughput screening in drug discovery

Stav: Absolvoval od 2014 do 2016.
Voltemarová Tereza

Cytotoxicity profiling of new potentially bioactive compounds using high throughput screening (HTS)

Stav: Absolvoval od 2019 do 2021.

Bachelor mentorship

Jamborová Petra

Establishment and characterization of anticancer drug resistant leukemic cell lines

Stav: Absolvoval od 2023 do 2024.
Synek Vojtěch

Cytotoxicity tests for high-throughput drug discovery

Stav: Absolvoval od 2014 do 2018.
Zabáková Dominika

Analysis of the cytotoxic effects of new chemical substances in HTS conditions

Stav: Absolvoval od 2021 do 2021.